Cancer associates with risk and severe events of COVID ‐19: A systematic review and meta‐analysis

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement

Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.

(2009) · PubMed Central · Cited by 44,859

Quantifying heterogeneity in a meta‐analysis

Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763

Clinical characteristics of coronavirus disease 2019 in China

Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263

Epidemiological and clinical characteristics of 99 cases of 2019 novel Coronavirus pneumonia in Wuhan, China: a descriptive study.

Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415

Clinical characteristics of 138 hospitalized patients with 2019 Novel Coronavirus-Infected pneumonia in Wuhan, China

Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148

La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19

Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention

Wu, Z., & McGoogan, J. M. (2020) · JAMA · doi:10.1001/jama.2020.2648 · Cited by 17,016

Predictors of in-hospital COVID-19 mortality: A comprehensive systematic review and meta-analysis exploring differences by age, sex and health conditions

Mesas, A. E., Cavero‐Redondo, I., Álvarez‐Bueno, C., Cabrera, M. A. S., de Andrade, S. M., Sequí‐Domínguez, I., & Martínez‐Vizcaíno, V. (2020) · PLoS ONE · doi:10.1371/journal.pone.0241742 · Cited by 245

Pre-existing health conditions and severe COVID-19 outcomes: an umbrella review approach and meta-analysis of global evidence

Treskova, M., Haas, L., Reda, S. A., Pilic, A., Borodova, A., Karimi, K., Koch, J., Nygren, T. M., Scholz, S. M., Schönfeld, V., et al. (2021) · BMC Medicine · doi:10.1186/s12916-021-02058-6 · Cited by 219

Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review

Galmiche, S., Nguyen, L. B. L., Tartour, É., de Lamballerie, X. N., Wittkop, L., Loubet, P., & Launay, O. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.09.036 · Cited by 207

Digital Health Applications in Oncology: An Opportunity to Seize

Parikh, R. B., Basen-Enquist, K. M., Bradley, C. J., Estrin, D. L., Levy, M. A., Lichtenfeld, J. L., Malin, B., McGraw, D., Meropol, N. J., Oyer, R. A., et al. (2022) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djac108 · Cited by 81

Highlights in ultrasound-targeted microbubble destruction-mediated gene/drug delivery strategy for treatment of malignancies

Li, H., Zhang, Y., Shu, H., Lv, W., Su, C., & Nie, F. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.121412 · Cited by 68

Determinants of COVID-19 Mortality in Patients With Cancer From a Community Oncology Practice in Brazil

Ferrari, B. L., Ferreira, C. G., Menezes, M., Marchi, P. D., Canedo, J., de Melo, A. C., Jacome, A. A. D. A., Reinert, T., Paes, R. D., Sodré, B., et al. (2021) · JCO Global Oncology · doi:10.1200/go.20.00444 · Cited by 53

New progresses on cell surface protein HSPA5/BiP/GRP78 in cancers and COVID-19

Li, T., Fu, J., Cheng, J., Elfiky, A. A., Wei, C., & Fu, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1166680 · Cited by 48

Newly diagnosed cancer and the COVID-19 pandemic: tumour stage migration and higher early mortality

Güven, D. C., Şahin, T. K., Yildirim, H. Ç., Çeşmeci, E., Incesu, F. G. G., Tahıllıoğlu, Y., Üçgül, E., Aksun, M. S., Gurbuz, S. C., Aktepe, O. H., et al. (2021) · BMJ Supportive & Palliative Care · doi:10.1136/bmjspcare-2021-003301 · Cited by 45

A systematic review of health sector responses to the coincidence of disasters and COVID-19

Sohrabizadeh, S., Yousefian, S., Bahramzadeh, A., & Vaziri, M. H. (2021) · BMC Public Health · doi:10.1186/s12889-021-10806-9 · Cited by 42

Quercetin potential effects against SARS‐CoV ‐2 infection and COVID ‐19‐associated cancer progression by inhibiting mTOR and hypoxia‐inducible factor‐1α ( HIF ‐1α)

Zalpoor, H., Bakhtiyari, M., Liaghat, M., Nabi‐Afjadi, M., & Ganjalıkhani-Hakemi, M. (2022) · Phytotherapy Research · doi:10.1002/ptr.7440 · Cited by 37

The intention to get COVID-19 vaccine and vaccine uptake among cancer patients: An extension of the theory of planned behaviour (TPB)

Servidio, R. C., Malvaso, A., Vizza, D., Valente, M., Campagna, M. R., Iacono, M. L., Martin, L. R., & Bruno, F. (2022) · Supportive Care in Cancer · doi:10.1007/s00520-022-07238-5 · Cited by 37

A systematic review and meta-analysis of regional risk factors for critical outcomes of COVID-19 during early phase of the pandemic

Kim, H., Hwang, H., Hong, H., Yim, J., & Lee, J. (2021) · Scientific Reports · doi:10.1038/s41598-021-89182-8 · Cited by 34

Impact of COVID-19 on Cancer Care Delivery in Africa: A Cross-Sectional Survey of Oncology Providers in Africa

Martei, Y. M., Rick, T. J., Fadelu, T. A., Ezzi, M. S., Hammad, N., Quadri, N. S., Rodrigues, B., Simonds, H. M., Grover, S., Incrocci, L., et al. (2021) · JCO Global Oncology · doi:10.1200/go.20.00569 · Cited by 31

The Deadly Duo of COVID-19 and Cancer!

Bora, V. R., & Patel, B. M. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.643004 · Cited by 32

Psychosocial Impact of Cancer Care Disruptions in Women With Breast Cancer During the COVID-19 Pandemic

Soriano, E. C., Perndorfer, C., Otto, A. K., Fenech, A. L., Siegel, S. D., Dickson-Witmer, D., Clements, L. I., & Laurenceau, J. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.662339 · Cited by 31

Correlation of SARS‑CoV‑2 to cancer: Carcinogenic or anticancer? (Review)

Li, Y., Ren, H.-C., & Cao, J.-H. (2022) · International Journal of Oncology · doi:10.3892/ijo.2022.5332 · Cited by 32

Antibody Responses to COVID-19 Vaccination in Cancer: A Systematic Review

Güven, D. C., Şahin, T. K., Kılıçkap, S., & Uckun, F. M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.759108 · Cited by 27

Thiopurines: Recent Topics and Their Role in the Treatment of Inflammatory Bowel Diseases

Tominaga, K., Sugaya, T., Tanaka, T., Kanazawa, M., Iijima, M., & Irisawa, A. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.582291 · Cited by 29

Heterogeneity and Risk of Bias in Studies Examining Risk Factors for Severe Illness and Death in COVID-19: A Systematic Review and Meta-Analysis

Degarege, A., Naveed, Z., Kabayundo, J., & Brett‐Major, D. M. (2022) · Pathogens · doi:10.3390/pathogens11050563 · Cited by 26

COVID‐19 impact on anxiety and depression in head and neck cancer patients: A cross‐sectional study

Rodrigues‐Oliveira, L., FONTES, E. K., Alves, C. G. B., Tonaki, J. O., Gueiros, L. A., Moutinho, K., Marta, G. N., Barros, L. R. C., Santos‐Silva, A. R., Brandão, T. B., et al. (2021) · Oral Diseases · doi:10.1111/odi.13876 · Cited by 24

Verbascoside—A Review of Its Antitumor Activities

Khalaf, H. A. A.-D., Jasim, R. A., & Ibrahim, I. T. (2021) · Pharmacology & Pharmacy · doi:10.4236/pp.2021.126011 · Cited by 24

Implementing Telehealth Music Therapy Services in an Integrative Oncology Setting: A Case Series

Folsom, S., Christie, A. J., Cohen, L. G., & Lopez, G. (2021) · Integrative Cancer Therapies · doi:10.1177/15347354211053647 · Cited by 24

Impaired seroconversion after SARS-CoV-2 mRNA vaccines in patients with solid tumours receiving anticancer treatment

Amatu, A., Pani, A., Patelli, G., Gagliardi, O. M., Loparco, M., Piscazzi, D., Cassingena, A., Tosi, F., Ghezzi, S., Campisi, D., et al. (2021) · European Journal of Cancer · doi:10.1016/j.ejca.2021.12.006 · Cited by 24

Is There a Link between Bisphenol A (BPA), a Key Endocrine Disruptor, and the Risk for SARS-CoV-2 Infection and Severe COVID-19?

Zahra, A., Sisu, C., Silva, E. A., Greca, S.-C. D. A., Randeva, H. S., Chatha, K. K., Kyrou, I., & Karteris, E. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9103296 · Cited by 23

Liver Injury and Elevated FIB-4 Define a High-Risk Group in Patients with COVID-19

Crișan, D., Avram, L., Grapa, C. M., Dragan, A., Rădulescu, D., Crişan, S., Grosu, A. I., Militaru, V., Buzdugan, E., Stoicescu, L., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm11010153 · Cited by 23

Mental Health and Adherence to COVID-19 Protective Behaviors among Cancer Patients during the COVID-19 Pandemic: An International, Multinational Cross-Sectional Study

Kassianos, A. P., Georgiou, A., Kyprianidou, M., Lamnisos, D., Ļubenko, J., Presti, G., Squatrito, V., Constantinou, M., Nicolaou, C., Papacostas, S., et al. (2021) · Cancers · doi:10.3390/cancers13246294 · Cited by 21

Covid-19 and radiotherapy: a systematic review after 2 years of pandemic

Piras, A., Venuti, V., D’Aviero, A., Cusumano, D., Pergolizzi, S., Daidone, A., & Boldrini, L. (2022) · Clinical and Translational Imaging · doi:10.1007/s40336-022-00513-9 · Cited by 22

Cancers and COVID-19 Risk: A Mendelian Randomization Study

Li, Z., Wei, Y., Zhu, G., Wang, M., & Zhang, L. (2022) · Cancers · doi:10.3390/cancers14092086 · Cited by 22

The Psychosocial Impact of COVID-19 on Older Adults with Cancer: A Rapid Review

Verma, R., Kilgour, H. M., & Haase, K. R. (2022) · Current Oncology · doi:10.3390/curroncol29020053 · Cited by 19

Integrated Bioinformatic Analysis of SARS-CoV-2 Infection Related Genes ACE2, BSG and TMPRSS2 in Aerodigestive Cancers

He, C., Hua, X., Sun, S., Li, S., Wang, J., & Huang, X. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s300127 · Cited by 19

SARS-Cov-2 infection in cancer patients, susceptibility, outcome and care

Alaeddini, M., & Etemad‐Moghadam, S. (2022) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2022.05.017 · Cited by 18

Immune Response to COVID-19 and mRNA Vaccination in Immunocompromised Individuals: A Narrative Review

Napuri, N., Curcio, D., Swerdlow, D. L., & Srivastava, A. K. (2022) · Infectious Diseases and Therapy · doi:10.1007/s40121-022-00648-2 · Cited by 18

Remdesivir Decreases Mortality in COVID-19 Patients with Active Malignancy

Jaroszewicz, J., Kowalska, J. D., Pawłowska, M., Rogalska, M., Zarębska‐Michaluk, D., Rorat, M., Lorenc, B., Czupryna, P., Sikorska, K., Piekarska, A., et al. (2022) · Cancers · doi:10.3390/cancers14194720 · Cited by 18

Identification of CKD, bedridden history and cancer as higher-risk comorbidities and their impact on prognosis of hospitalized Omicron patients: a multi-centre cohort study

Chen, X., Wang, H., Ai, J., Shen, L., Lin, K., Yuan, G., Sheng, X., Jin, X., Deng, Z., Xu, J., et al. (2022) · Emerging Microbes & Infections · doi:10.1080/22221751.2022.2122581 · Cited by 19

COVID-19 Risk Factors for Cancer Patients: A First Report with Comparator Data from COVID-19 Negative Cancer Patients

Russell, B. A., Moss, C. L., Palmer, K. R., Sylva, R., D’Souza, A., Wylie, H., Haire, A., Cahill, F., Steel, R., Hoyes, A., et al. (2021) · Cancers · doi:10.3390/cancers13102479 · Cited by 16

Factors Associated with SARS-CoV-2 Infection Risk among Healthcare Workers of an Italian University Hospital

Modenese, A., Casolari, L., Rossi, G., Vecchia, E. D., Glieca, F., D’Elia, C., Garavini, D., Righi, E., Mariani, S., Venturelli, L., et al. (2021) · Healthcare · doi:10.3390/healthcare9111495 · Cited by 16

Are patients with cancer at higher risk of COVID-19-related death? A systematic review and critical appraisal of the early evidence

Freeman, V., Hughes, S., Carle, C., Campbell, D. J., Egger, S. J., Hui, H., Yap, S., Deandrea, S., Caruana, M., Onyeka, T. C., et al. (2022) · Journal of Cancer Policy · doi:10.1016/j.jcpo.2022.100340 · Cited by 16

Clinical Impact of the COVID-19 Pandemic in Mexican Patients with Thoracic Malignancies

Arrieta, O. G., Lara‐Mejía, L., Bautista-González, E., Heredia, D., Turcott, J. G., Barrón, F., Ramos-Ramírez, M., Cabrera-Miranda, L. A., Padilla, M.-Á. S., Aguerrebere, M., et al. (2021) · The Oncologist · doi:10.1002/onco.13962 · Cited by 15

Blood Cytokine Analysis Suggests That SARS-CoV-2 Infection Results in a Sustained Tumour Promoting Environment in Cancer Patients

Winter, F. D., Hotterbeekx, A., Huizing, M. T., Konnova, A., Fransén, E., Jongers, B. ‘., Jairam, R. K., averbeke, V. V., Moons, P., Roelant, E., et al. (2021) · Cancers · doi:10.3390/cancers13225718 · Cited by 13

Quality of life and occupational performance of children with cancer in the era of the COVID-19 pandemic in terms of rehabilitation

Önal, G., Yılmaz, G. G., & Huri̇, M. (2021) · Quality of Life Research · doi:10.1007/s11136-021-02857-7 · Cited by 14

Is Cancer an Independent Risk Factor for Fatal Outcomes of Coronavirus Disease 2019 Patients?

Xu, J., Xiao, W., Shi, L., Wang, Y., & Yang, H. (2021) · Archives of Medical Research · doi:10.1016/j.arcmed.2021.05.003 · Cited by 13

Refusal of anti-coronavirus disease 2019 vaccination in cancer patients: Is there a difference between the sexes?

Stoeklé, H., Sekkate, S., Angellier, É., Hervé, C., & Beuzeboc, P. (2021) · European Journal of Cancer · doi:10.1016/j.ejca.2021.06.048 · Cited by 13

SARS-CoV-2 Infection in Cancer Patients: A Population-Based Study

Zorzi, M., Guzzinati, S., Avossa, F., Fedeli, U., Calcinotto, A., & Rugge, M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.730131 · Cited by 12

Safety of systemic anti-cancer treatment in oncology patients with non-severe COVID-19: a cohort study

van Marcke, C., Honoré, N., van der Elst, A., Beyaert, S. P., Derouane, F., Dumont, C., Nana, F. A., Baurain, J., Borbath, I., Collard, P., et al. (2021) · BMC Cancer · doi:10.1186/s12885-021-08349-8 · Cited by 11

COVID−19 hospitalization increases the risk of developing glioblastoma: a bidirectional Mendelian-randomization study

Dong, J., Wang, S., Xie, H., Mou, Y., Zhu, H., Peng, Y., Xi, J., Zhong, M., Xie, Z., Jiang, Z., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1185466 · Cited by 11

Safety and preliminary efficacy of the Gam-COVID-Vac vaccine and outcomes of SARS-CoV-2 infection in Russian patients with genitourinary malignancies

Tsimafeyeu, I. V., Волкова, М. И., Алексеева, Г., Беркут, М. В., Носов, А. К., Валерьевич, М. И., Андрианов, А. Н., Semenov, A., Borisov, P. S., Zukov, R. A., et al. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01205-z · Cited by 10

Long-term effects of COVID-19 on cancer patients: the experience from Guy’s Cancer Centre

Monroy‐Iglesias, M. J., Tremble, K., Russell, B. A., Moss, C. L., Dolly, S. O., Sita-Lumsden, A. R., Cortellini, A., Pinato, D. J., Rigg, A. S., Karagiannis, S. N., et al. (2022) · Future Oncology · doi:10.2217/fon-2022-0088 · Cited by 10

The Needs of Older Adult Cancer Survivors During COVID-19: Implications for Oncology Nursing

Kilgour, H. M., Galica, J., Oliffe, J. L., & Haase, K. R. (2021) · Seminars in Oncology Nursing · doi:10.1016/j.soncn.2021.151229 · Cited by 9

Predictors of poor serologic response to COVID-19 vaccine in patients with cancer: a systematic review and meta-analysis

Yang, W.-X., Zhang, D.-X., Li, Z., & Zhang, K. (2022) · European Journal of Cancer · doi:10.1016/j.ejca.2022.05.031 · Cited by 9

A Review on the Impact of the SARS-CoV-2 Omicron Subvariant on Elderly Patients with Diverse Co-Morbidities

Khadela, A. D., Soni, S., Megha, K., Bhagat, S. U., & Chavda, V. P. (2023) · Biologics · doi:10.3390/biologics3020008 · Cited by 9

The impact of cancer on the severity of disease in patients affected with COVID-19: an umbrella review and meta-meta-analysis of systematic reviews and meta-analyses involving 1,064,476 participants

Arayıcı, M. E., Başbınar, Y., & Ellıdokuz, H. (2022) · Clinical and Experimental Medicine · doi:10.1007/s10238-022-00911-3 · Cited by 9

Vitamin D Deficiency and COVID-19: A Biological Database Study on Pathways and Gene-Disease Associations

Alcalá-Santiago, Á., Rodríguez‐Barranco, M., Rava, M., Jiménez‐Sousa, M. Á., Gil, Á., Sánchez, M., & Molina‐Montes, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214256 · Cited by 9

Dying with Cancer and COVID-19, with Special Reference to Lung Cancer: Frailty as a Risk Factor

Strang, P. M., & Schultz, T. (2022) · Cancers · doi:10.3390/cancers14236002 · Cited by 8

Effect of antitumor therapy on cancer patients infected by SARS‐CoV‐2: A systematic review and meta‐analysis

Li, P., Li, L., Wang, S., Liu, Y., Zhou, L., & Xia, S. (2021) · Cancer Medicine · doi:10.1002/cam4.3754 · Cited by 7

Prognostic factors in patients with advanced cancer and COVID-19: a cohort from the Palliative Care Unit of the Brazilian National Cancer Institute

de Oliveira, L. C., Rosa, K. S. D. C., Borsatto, A. Z., de Oliveira, L. A. F., de Freitas, R., & Sampaio, S. G. D. S. M. (2021) · Supportive Care in Cancer · doi:10.1007/s00520-021-06149-1 · Cited by 7

Distinct Symptoms and Underlying Comorbidities with Latitude and Longitude in COVID-19: A Systematic Review and Meta-Analysis

Yong, T., Wu, Q., Li, H., Wu, Q., Xie, Y. F., Li, L., & Chen, H. (2022) · Canadian Respiratory Journal · doi:10.1155/2022/6163735 · Cited by 7

Perceived COVID-19 pandemic impact and protective factors predicting patient-reported depression and anxiety in individuals living with cancer

Fortune, E. E., Zaleta, A. K., & Morris, V. G. (2023) · Journal of Patient-Reported Outcomes · doi:10.1186/s41687-023-00571-1 · Cited by 6

Clinical characteristics and factors associated with COVID-19-related death and morbidity among hospitalized patients with cancer: a Swedish cohort study

Ullgren, H., Camuto, A., Rosas, S., Pahnke, S., Ginman, B., Enblad, G., Glimelius, I. C., Fransson, P., Friesland, S., & Liu, L. L. (2021) · Acta Oncologica · doi:10.1080/0284186x.2021.1958005 · Cited by 6

Outcomes of SARS-CoV-2 infection in cancer versus non-cancer-patients: a population-based study in northeastern Italy

Rugge, M., Zorzi, M., Guzzinati, S., Stocco, C. F., Avossa, F., Zotto, S. D., Clagnan, E., Bricca, L., Maso, L. D., & Serraino, D. (2022) · Tumori Journal · doi:10.1177/03008916211073771 · Cited by 6

Strategies for Cardio-Oncology Care During the COVID-19 Pandemic

Abraham, S., Manohar, S. A., Patel, R. P., Saji, A. M., Dani, S. S., & Ganatra, S. (2022) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-022-00965-2 · Cited by 6

Changes in breast cancer staging trends among Egyptian women after COVID-19: A retrospective single-center study

Wahab, M. H. A. E., Ibrahim, A. H., Gado, O., Bahbah, A., Fadlalla, W. M., Fakhry, S., Mamdouh, M. M., Kamel, M. M., Moaz, I. M., Rabea, A. M., et al. (2023) · International Journal of Immunopathology and Pharmacology · doi:10.1177/03946320231152835 · Cited by 6

Immunogenicity and Safety of Vaccines against Coronavirus Disease in Actively Treated Patients with Solid Tumors: A Prospective Cohort Study

Baek, Y. J., Lee, Y.-J., Park, S. R., Kim, K. H., Beom, S., Lee, C., Shin, S. J., Rha, S. Y., Kim, S., Lee, K. H., et al. (2023) · Cancer Research and Treatment · doi:10.4143/crt.2022.1541 · Cited by 6

Anti-SARS-CoV-2 glyco-humanized polyclonal antibody XAV-19: phase II/III randomized placebo-controlled trial shows acceleration to recovery for mild to moderate patients with COVID-19

Poulakou, G., Royer, P., Evgeniev, N., Evanno, G., Shneiker, F., Marcelin, A., Vanhove, B., Duvaux-Miret, O., Marot, S., & Cálvez, V. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1330178 · Cited by 5

Patient and clinician nudges to improve symptom management in advanced cancer using patient-generated health data: study protocol for the PROStep randomised controlled trial

Parikh, R. B., Ferrell, W. J., Wakim, J., Williamson, J., Khan, N., Kopinsky, M., Balachandran, M., Gabriel, P. E., Zhang, Y., Schuchter, L. M., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-054675 · Cited by 5

Anti-tumour drugs of marine origin currently at various stages of clinical trials (review)

Бочарова, Е. А., Копытина, Н. И., & Slynko, Е. Е. (2021) · Regulatory Mechanisms in Biosystems · doi:10.15421/022136 · Cited by 5

Has the COVID-19 pandemic affected the psychological state of arab cancer patients?

Madkhali, N. A. B., Ameri, A., Al‐Naamani, Z., Madkhali, M., Alshammari, B., & Maqbali, M. A. H. A. (2022) · Current Psychology · doi:10.1007/s12144-022-03414-2 · Cited by 5

Protein expression of transmembrane protease serine 4 in the gastrointestinal tract and in healthy, cancer, and SARS‑CoV‑2 infected lungs

Kerslake, R., Randeva, H. S., Jonigk, D. D., Werlein, C., Robertus, J. L., Katopodis, P., Jasker, P., Spandidos, D. A., Kyrou, I., & Karteris, E. (2022) · Molecular Medicine Reports · doi:10.3892/mmr.2022.12654 · Cited by 5

COVID ‐19 and the risk to cancer patients in China

Williams, J., & Stebbing, J. (2020) · International Journal of Cancer · doi:10.1002/ijc.33325 · Cited by 5

Altered ACE2 and interferon landscape in the COVID-19 microenvironment correlate with the anti-PD-1 response in solid tumors

Subbarayan, K., Al‐Samadi, A., Schäfer, H., Massa, C., Salo, T. A., Biehl, K., Vaxevanis, C., Ulagappan, K., Wahbi, W., Reimers, M., et al. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05520-9 · Cited by 4

Infectious Diseases

Li, H., Terrando, N., & Gelbard, H. A. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-55529-9_24 · Cited by 4

Impact of the COVID-19 pandemic on the diagnosis and treatment of onco-hematologic patients: a discussion paper

Bouza, E., Martı́n, M., Alés, J. E., Aragonés, N., Barragán, B., de la Cámara, R., del Pozo, J. L., García‐Gutiérrez, V., García‐Sánz, R., Gracia, D., et al. (2022) · Revista Española de Quimioterapia · doi:10.37201/req/087.2022 · Cited by 6

COVID-19 en pacientes con cáncer: revisión sistemática

Castañeda, C. A., Castillo, M., Rojas, J. L. V., Fuentes, H. A., & Gómez, H. (2020) · Revista Peruana de Medicina Experimental y Salud Pública · doi:10.17843/rpmesp.2020.374.5976 · Cited by 4

Optimization of Patient Management During the COVID-19 Pandemic: Chest CT Scan and PCR as Gatekeepers of the Radiation Therapy Workflow

Sun, R., Ammari, S., Bockel, S., Achkar, S., Merad-Boudia, M., Dercle, L., Rivera, S., Chargari, C., & Deutsch, É. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.556334 · Cited by 4

Methodological Considerations on COVID-19 Mortality in Cancer Patients: A Systematic Review and Meta-Analysis

Zewde, M. G., Alpert, N., & Taioli, E. (2022) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkac063 · Cited by 3

Safeguarding COVID-19 and cancer management: drug design and therapeutic approach

Thorat, N. D., Pricl, S., Parchur, A. K., Somvanshi, S. B., Li, Q., Umrao, S., & Townley, H. E. (2021) · Open Research Europe · doi:10.12688/openreseurope.13841.1 · Cited by 3

Outcome of COVID-19 infection in people with diabetes mellitus or obesity in the primary care setting in Catalonia, Spain: A retrospective cohort study of the initial three waves

Mauricio, D., Vlacho, B., Ortega, E., Cos, X., Mata‐Cases, M., Real, J., Fernández‐Camins, B., & Franch‐Nadal, J. (2022) · Primary care diabetes · doi:10.1016/j.pcd.2022.12.002 · Cited by 3

Impact of diabetes and Krebs von den Lungen‐6 on coronavirus disease 2019 severity: A single‐center study from Japan

Yakushiji, Y., Motoyama, K., Fukuda, M., Takahashi, H., Kimura, M., Tazoe, S., Iida, H., Tamai, A., Sakura, T., Isaka, Y., et al. (2022) · Journal of Diabetes Investigation · doi:10.1111/jdi.13784 · Cited by 3

Conceptual Framework for Cancer Care During a Pandemic Incorporating Evidence From the COVID-19 Pandemic

Milch, V., Nelson, A. E., Austen, M., Hector, D., Turnbull, S., Sathiaraj, R., Vartanian, C. D., Wang, R., Anderiesz, C., & Keefe, D. M. K. (2022) · JCO Global Oncology · doi:10.1200/go.22.00043 · Cited by 3

SARS-CoV-2 Virus in Cancer Patients: A New Unknown in an Unsolved Equation

Martín, M., Vallejo, C., López‐Campos, F., Quereda, C., Muñóz, T., Sánchez‐Conde, M., Dominguez, J. A., Soriano, C., Martín, M., Carantoña, C. S., et al. (2022) · Oncology · doi:10.1159/000525802 · Cited by 2

The SARS-COV-2 Seroprevalence among Oncology Patients

Kgatle, M., Das, R., Lawal, I. O., Boshomane, T. G., Mokoala, K. M. G., Gaspar, C., Mbokazi, L., Nkambule, N., Gow, V., Ndlovu, H., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12020529 · Cited by 4

The association of sickle cell disorder with adverse outcomes in COVID‐19 patients: A meta‐analysis

Liang, T., Guo, K., Ni, P., Duan, G., & Zhang, R. (2023) · Journal of Medical Virology · doi:10.1002/jmv.29120 · Cited by 2

Clinical Characteristics of Coronavirus Disease 2019: A Review on Laboratory Tests, Comorbidity, and Complication

Qiu, X., Tian, Y., Jiang, X. J., Zhang, Q., & Huang, J. (2020) · Global Clinical and Translational Research · doi:10.36316/gcatr.02.0035 · Cited by 2

DEPRESSION IN CANCER PATIENTS DURING COVID-19 PANDEMIC.

Otroshchenko, P., Otroshchenko, N., & Iryna, O. (2021) · Ukrainian Scientific Medical Youth Journal · doi:10.32345/usmyj.3(125).2021.23-31 · Cited by 2

Risk and severity of SARS-CoV-2 infection in breast cancer patients undergoing a structured infection screening program at the University and Hospital Trust of Verona

Zanelli, S., Fiorio, E., Zampiva, I., Zacchi, F., Borghesani, G., Giontella, E., Parolin, V., Biondani, P., Zuliani, S., Dieci, M. V., et al. (2022) · Annals of Oncology · doi:10.1016/j.annonc.2022.02.227 · Cited by 2

Clinical Characteristics and Outcomes of Children and Adolescents With Cancer Infected With SARS-CoV-2 at a Tertiary Care Medical Center in Jordan

Al-Sweedan, S. A., Samara, D. N., Hamaidi, M. A., Al-Hamad, M. M., Alsweedan, D., & Jaradat, S. A. (2022) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0000000000002460 · Cited by 2

Impact of COVID-19 on emergency department visits among palliative home care recipients: a retrospective population-based cohort study in the Piedmont region, Italy

Scacchi, A., Conti, A., Politano, G. M. M., Dalmasso, M., Ostellino, S., & Gianino, M. M. (2022) · Palliative Care and Social Practice · doi:10.1177/26323524221136880 · Cited by 2

Cancer patients with COVID-19: does prior nutritional risk associated with cancer indicate a poor prognosis for COVID-19?

de Oliveira, L. C., Rosa, K. S. D. C., Pedrosa, A. P., da Silva, N. F., dos Santos, L. A., & Wiegert, E. V. M. (2023) · Einstein (São Paulo) · doi:10.31744/einstein_journal/2023ao0172 · Cited by 2

SARS-CoV-2 Infection, Vaccination and Risk of Death in People with An Oncological Disease in Northeast Italy

Mangone, L., Rossi, P. G., Taborelli, M., Toffolutti, F., Mancuso, P., Maso, L. D., Gobbato, M., Clagnan, E., Zotto, S. D., Ottone, M., et al. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13091333 · Cited by 2

Delphi Panel Consensus Statement Generation: COVID-19 Vaccination Recommendations for Immunocompromised Populations in the European Union

Paranilam, J., Arcioni, F., Franco, A., Lai, K. Z. H., Brown, J. A., & Kimball-Carroll, S. (2024) · Infectious Diseases and Therapy · doi:10.1007/s40121-024-01051-9 · Cited by 1

Social Distancing to Avoid SARS-CoV-2 Infection in Cancer and Noncancer Patients

Kloecker, G. H., Nolan, J. R., Korbee, L. L., Calhoun, R. F., Logan, B. B., Flora, D., Flora, D. B., & Hartman, P. E. (2022) · Journal of Patient Safety · doi:10.1097/pts.0000000000001058 · Cited by 1

Variation in Time Between Testing Positive for COVID-19 and Hospital Admission by Race/Ethnicity and Insurance Status

Porter, A., Brown, C. C., Rodriguez, A., Zohoori, N., Wells, S., Crump, A. A., Romero, J., & Tilford, J. M. (2023) · Journal of Health Care for the Poor and Underserved · doi:10.1353/hpu.2023.a912718 · Cited by 1

Similar risk of hospitalization and lethality from COVID-19 in transplant recipients and waitlisted patients: A comparative analysis

Chávez, A. C. F., León, G. Y. O., León, E. E. Á., Moreno-Nuñez, P., Tomás, J. P., & Andrés, J. M. A. (2025) · Enfermedades infecciosas y microbiologia clinica (English ed ) · doi:10.1016/j.eimce.2025.02.005 · Cited by 1

Serological Response After the Fourth Dose of COVID-19 Vaccine in Highly Immunosuppressed Patients

Chávez, A. C. F., López, P. N., de‐Andrés‐Martín, A., Carmona, D. L. S., León, G. Y. O., & Andrés, J. M. A. (2025) · Vaccines · doi:10.3390/vaccines13100994 · Cited by 1

COVID-19 infection and cancer regression: a review of current evidence, potential mechanisms, and clinical perspectives on a Paradoxical phenomenon

Ogieuhi, I. J., Ajekiigbe, V. O., Agbo, C. E., Chidera Stanley Anthony, M., Christopher, A. A., Onyehalu, J. C., Agu, M. C., Mbaji, M. S., Akingbola, A., Ahmed, B., et al. (2025) · Infectious Agents and Cancer · doi:10.1186/s13027-025-00704-9 · Cited by 2

Who Still Pays the Price of SARS-CoV-2 in the Vaccination Era? Evidence from Primary Healthcare in Greece

Tichala, D., Papagiannis, D., & Kotsiou, O. S. (2026) · COVID · doi:10.3390/covid6050076 · Cited by 1

Symptom Management and Support in Dying Patients with Cancer and Coronavirus Disease-19—A Register-Based Study

Hedman, C., Strang, P. M., Lundström, S., & Martinsson, L. (2023) · Journal of Palliative Care · doi:10.1177/08258597231157622 · Cited by 1

The impact of the COVID-19 pandemic on health-related quality of life in head and neck cancer survivors: An observational cohort studs

Lissenberg-Witte, B. I., Jansen, F., de Jong, R. J. B., Lamers, F., Leemans, C. R., Oosting, S. F., Takes, R. P., & Leeuw, I. M. V. (2023) · Oral Oncology Reports · doi:10.1016/j.oor.2023.100059 · Cited by 1

Retrospective Case-Control Study of REGEN-COV (Casirivimab and Imdevimab) Therapy for Patients with COVID-19 and Cancer Using the United States MarketScan® Database

Takemoto, K. (2023) · Oncology · doi:10.1159/000533614 · Cited by 1

Impacto psicológico del COVID-19 en los pacientes de Oncología Médica, Hemato-Oncología y Oncología Radioterápica de un hospital público en España

Castells, E. F., Toader, I. D., Carpio, A., Narváez, A., Valverde, A. G., & Rodríguez, L. P.-A. (2023) · Psicooncología · doi:10.5209/psic.91235 · Cited by 2

COGNITIVE ASPECTS OF DEPRESSION IN VICTIMS OF RADIATION ACCIDENTS, THE COVID/19 PANDEMIC, AND WARS

Otroshchenko, N. (2023) · Проблеми радіаційної медицини та радіобіології = Problems of Radiation Medicine and Radiobiology · doi:10.33145/2304-8336-2023-28-75-92 · Cited by 1

Prevalence and risks of severe events for cancer patients with COVID-19 infection: a systematic review and meta-analysisPreprint

Su, Q., Hu, J., Lin, H., Zhang, Z., Zhu, E. C., Zhang, C., Wang, D., Gao, Z., & Cao, B. (2020) · medRxiv · doi:10.1101/2020.06.23.20136200 · Cited by 4

Cancer is associated with severe disease in COVID-19 patients: a systematic review and meta-analysis

Ofori‐Asenso, R., Ogundipe, O., Agyeman, A. A., Chin, K. L., Mazidi, M., Ademi, Z., Bruin, M. L. D., & Liew, D. (2020) · ecancermedicalscience · doi:10.3332/ecancer.2020.1047 · Cited by 40

Cancer is associated with the severity and mortality of patients with COVID-19: a systematic review and meta-analysisPreprint

Gao, Y., Liu, M., Shi, S., Chen, Y., Sun, Y., Chen, J., & Tian, J. (2020) · medRxiv · doi:10.1101/2020.05.01.20087031 · Cited by 16

Prevalence of cancer as a comorbid in COVID-19 patients and their characteristics: a meta-analysis study

Sitanggang, J. S., Siregar, K. B., Sitanggang, H. H., & Vinolina, N. S. (2022) · F1000Research · doi:10.12688/f1000research.53539.2 · Cited by 1

Epidemiological and clinical characteristics of cancer patients with COVID-19: A systematic review and meta-analysis of global data

Kong, X., Qi, Y., Huang, J., Zhao, Y. W., Zhan, Y., Qin, X., Qi, Z., Atanda, A. J., Zhang, L., Fang, Y., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.02.012 · Cited by 18